.Ideaya Biosciences is betting $400 thousand in biobucks that a bispecific antibody-drug conjugate (...
.We currently understand that Takeda is actually expecting to locate a road to the FDA for epilepsy ...
.Immunology biotech VBI Vaccinations is actually diverting precariously near the defining moment, al...
.It's challenging to muscle in on a space as competitive as immunology, but Celldex Therapies feels ...
.Boehringer Ingelheim is actually offering up to $1.3 billion for Nerio Rehabs and also a preclinica...
.Ventyx Biosciences' Crohn's illness medicine did not help people achieve remission in a period 2 tr...
.Knowledge Rehabs' phase 2 sparkle trial has taken several of the gloss off the Alzheimer's ailment ...
.Bristol Myers Squibb has had a whiplash change of mind on its BCMA bispecific T-cell engager, halti...
.Charles Baum, M.D., Ph.D., who looked after Mirati Therapeutics' $ 5.8 billion purchase to Bristol ...
.After reaching out to more than 200 companies to partner a Tourette syndrome treatment that showed ...